. 2015 Jun 21;290(32):19666–19680. doi: 10.1074/jbc.M115.660043

TABLE 2.

Maribavir susceptibility phenotypes of UL97 mutant viruses

Strain^a	UL97 genotype^b	Maribavir EC₅₀^c	Replicates^d
		μm
T3261	Wild type	0.12 ± 0.03	22
T3260	C151G/C428G/C693G	0.03 ± 0.01	13
T3719	C151G/W368A/C428G/C693G	35 ± 7	12
T3727	W368A	27 ± 7	12

^a Serial number of recombinant CMV strain derived by transfection of bacterial artificial chromosome into fibroblasts.

^b Mutation induced into bacterial artificial chromosome and recombinant virus.

^c Mean drug concentration (μm) required to reduce secreted alkaline phosphatase growth by 50% at 6–7 days postinfection.

^d Number of assays.